These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus]. Takamatsu J Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864 [No Abstract] [Full Text] [Related]
5. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Johnson JL; Wolf SL; Kabadi UM Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835 [TBL] [Abstract][Full Text] [Related]
6. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update]. Ravina A; Minuchin O Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798 [No Abstract] [Full Text] [Related]
8. [Combination therapy of oral hypoglycemic agents which enhance the efficacy of insulin therapy]. Hirose T Nihon Rinsho; 2012 May; 70 Suppl 3():669-77. PubMed ID: 22768596 [No Abstract] [Full Text] [Related]
9. Insulin initiation in Type 2 diabetes. Page S Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011 [No Abstract] [Full Text] [Related]
10. [Fear of the injection must not be an argument. Every second type 2 diabetic patient needs insulin]. MMW Fortschr Med; 2002 Dec; 144(49):60. PubMed ID: 12577748 [No Abstract] [Full Text] [Related]
11. [Minor differences in outcome comparing early vs. later initiation of medicamentous blood glucose control in type 2 diabetic patients]. Ritzman P Praxis (Bern 1994); 1999 Aug; 88(31-32):1289-90. PubMed ID: 10479970 [No Abstract] [Full Text] [Related]
12. [Combination therapy with sulfonylurea plus insulin in "secondary failure" of type 2 diabetes]. Lotz N Ther Umsch; 1990 Jan; 47(1):49-54. PubMed ID: 2408182 [TBL] [Abstract][Full Text] [Related]
13. Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea. Allen BT; Feinglos MN; Lebovitz HE Arch Intern Med; 1985 Oct; 145(10):1900-3. PubMed ID: 3899039 [No Abstract] [Full Text] [Related]
14. [Clinical characteristics of withdrawal from insulin therapy in NIDDM]. Kanda T; Imano E; Iida M; Kawamori R Nihon Rinsho; 1997 Nov; 55 Suppl():727-32. PubMed ID: 9434555 [No Abstract] [Full Text] [Related]
15. Combination therapy for NIDDM: has its time arrived? Menke J S D J Med; 1995 Aug; 48(8):246-7. PubMed ID: 7569874 [No Abstract] [Full Text] [Related]
16. The combination of insulin and oral hypoglycaemic drugs: a continuous challenge. Quatraro A; Giugliano D Diabete Metab; 1993; 19(2):219-24. PubMed ID: 8339852 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy. Yoshida M; Asai M; Miyata M; Ogawa K; Maeda H; Oiso Y Diabetes Res Clin Pract; 2012 Jun; 96(3):e55-6. PubMed ID: 22257418 [No Abstract] [Full Text] [Related]
18. Insulin regimens in type 2 diabetes. Cordido F N Engl J Med; 2010 Mar; 362(10):960; author reply 960. PubMed ID: 20225351 [No Abstract] [Full Text] [Related]
19. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria. Winkelmayer WC; Stedman MR; Pogantsch M; Wieninger P; Bucsics A; Asslaber M; Bauer R; Burkhardt T; Schautzer A; Brookhart MA; Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):57-65. PubMed ID: 21182153 [TBL] [Abstract][Full Text] [Related]
20. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy]. Dakhli S; Lamine S; Lamine F; Trabelsi N; Aouididi F; Zouaoui C; Mami FB; Achour A Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]